Use of liraglutide in type 1 diabetes : implications for management

Research output: Contribution to journalArticlepeer-review

Abstract

Why do people with type 1 diabetes have such difficulty achieving euglycaemia? An inverse association exists between reductions in hyperglycaemia and increasing hypoglycaemia: as patients approach euglycaemia, the key factor preventing further improvement is hypoglycaemia. Even mild hypoglycaemia is associated with reductions in quality of life. Management of glycaemia in type 1 diabetes therefore entails more than preventing increases in glucose and correcting hyperglycaemia promptly when it occurs; it is also critical to prevent hypoglycaemia.
Original languageEnglish
Pages (from-to)190-191
Number of pages2
JournalThe Lancet Diabetes and Endocrinology
Volume4
Issue number3
DOIs
Publication statusPublished - 2016

Keywords

  • diabetes
  • glucagon-like peptide 1
  • glucose
  • hyperglycaemia
  • hypoglycaemia
  • insulin

Fingerprint

Dive into the research topics of 'Use of liraglutide in type 1 diabetes : implications for management'. Together they form a unique fingerprint.

Cite this